ArticleEClinicalMedicine2023

STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancreatic cancer: An open label, phase I/IIa trial.

Toshio Fujisawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.